References
- Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016;23(5):218–226.
- Foris V, Kovacs G, Matucci-Cerinic M, et al. PL-7 positive antisynthetase syndrome and pulmonary hypertension. J Rheumatol. 2013;40(10):1777–1779.
- Hervier B, Meyer A, Dieval C, et al. Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J. 2013;42(5):1271–1282.
- Handa T, Nagai S, Kawabata D, et al. Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med. 2005;44(4):319–325.
- Taniguchi Y, Horino T, Kato T, et al. Acute pulmonary arterial hypertension associated with anti-synthetase syndrome. Scand J Rheumatol. 2010;39(2):179–180.
- Chatterjee S, Farver C. Severe pulmonary hypertension in anti-Jo-1 syndrome. Arthritis Care Res (Hoboken)). 2010;62(3):425–429.
- Kowal-Bielecka O, Fransen J, Avouac J, EUSTAR Coauthors, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327–1339.
- Coghlan JG, Denton CP, Grünig E, on behalf of the DETECT study group, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–1349.
- Erçen Diken Ö, Çiledağ A, Küçükşahin O, et al. Pulmonary arterial hypertension in antisynthetase syndrome without myositis. Tuberk Toraks. 2013;61(2):170–173.
- Aithala R, Alex AG, Danda D. Pulmonary hypertension in connective tissue diseases: an update. Int J Rheum Dis. 2017;20(1):5–24.
- Cavagna L, Prisco E, Montecucco C, et al. Pulmonary arterial hypertension in antisynthetase syndrome: comment on the article by Chatterjee and Farver. Arthritis Care Res (Hoboken)). 2011;63(4):633–634.